Symposium 4 “Sentinel Node Navigation Surgery in the Broncho-esophageal Region” —Introduction

2019 ◽  
Vol 70 (2) ◽  
pp. 83-84
Author(s):  
Y. Hasegawa
Keyword(s):  
Sentinel Node ◽  
Navigation Surgery ◽  
Sentinel Node Navigation Surgery

Sentinel Node Navigation Surgery with Combination Method with Dye and Radioisotopes for Malignant Melanoma

2006 ◽  
Vol 68 (3) ◽  
pp. 274-279 ◽  
Author(s):  
Akira TAKAHASHI ◽  
Naoya YAMAZAKI ◽  
Akifumi YAMAMOTO ◽  
Kouji YOSHINO ◽  
Kenjiro NAMIKAWA ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Sentinel Node ◽  
Combination Method ◽  
Navigation Surgery ◽  
Sentinel Node Navigation Surgery

scholarly journals Sentinel node navigation surgery for gastroduodenal neuroendocrine tumors

Medicine ◽  
2016 ◽  
Vol 95 (26) ◽  
pp. e4063 ◽  
Author(s):  
Takaaki Arigami ◽  
Yoshikazu Uenosono ◽  
Shigehiro Yanagita ◽  
Keishi Okubo ◽  
Takashi Kijima ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Neuroendocrine Tumors ◽  
Navigation Surgery ◽  
Sentinel Node Navigation Surgery

scholarly journals Long‑term outcome following sentinel node navigation surgery for cT1 gastric cancer

2019 ◽  
Author(s):  
Yoshihisa Yaguchi ◽  
Hironori Tsujimoto ◽  
Shuichi Hiraki ◽  
Nozomi Ito ◽  
Shinsuke Nomura ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Sentinel Node ◽  
Navigation Surgery ◽  
Sentinel Node Navigation Surgery ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals Comparison of lymphatic complications between sentinel node navigation surgery and pelvic lymphadenectomy in patients with cervical cancer

2020 ◽  
Vol 50 (5) ◽  
pp. 543-547
Author(s):  
Shinichi Togami ◽  
Rintaro Kubo ◽  
Toshihiko Kawamura ◽  
Shintaro Yanazume ◽  
Masaki Kamio ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Lower Extremity ◽  
Sentinel Node ◽  
Median Number ◽  
Pelvic Lymphadenectomy ◽  
Navigation Surgery ◽  
Sentinel Node Navigation Surgery ◽  
Iliac Node ◽  
Early Cervical Cancer ◽  
Lymphatic Complications

Abstract Background Sentinel node navigation surgery (SNNS) has been frequently used in early cervical cancer. However, the incidence and potential reduction of lymphatic complications following the removal of the sentinel lymph node remain unknown. Thus, this study aimed to evaluate the occurrence of lymphatic complications post sentinel node navigation surgery in patients with early cervical cancer. Methods A total of 167 patients, including 70 and 97 patients who had undergone SNNS and pelvic lymphadenectomy (PLA), respectively, were enrolled in this study. We compared the lymphatic complications (lower extremity lymphedema and pelvic lymphocele) between the SNNS and PLA groups. Results The median number of sentinel lymph nodes removed was 2 (range: 1–14). Among the 70 patients in the SNNS group, there were 0 (0%) and 3 (4.3%) occurrences of lower extremity lymphedema and pelvic lymphocele, respectively. The occurrences of lower extremity lymphedema and pelvic lymphocele were significantly lower in the SNNS group than in the PLA group, despite circumflex iliac node removal. Conclusions The occurrence of lymphatic complications (lower extremity lymphedema and pelvic lymphocele) was significantly lower in the SNNS group than in the PLA group. We found that SNNS, and not PLA, was the best treatment option for preventing the development of lower extremity lymphedema and pelvic lymphocele, despite circumflex iliac node preservation.

Multi-center prospective study on sentinel node navigation surgery in early breast cancer

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 606-606
Author(s):  
S. Imoto ◽  
M. Kitajima ◽  
T. Aikou ◽  
Y. Kitagawa
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Adverse Events ◽  
Prospective Study ◽  
Sentinel Node ◽  
Early Breast Cancer ◽  
Lymphatic Mapping ◽  
Axillary Lymph ◽  
Navigation Surgery ◽  
Sentinel Node Navigation Surgery

606 Background: Sentinel node navigation surgery (SNNS) is a standard technique to identify lymph node metastases in clinically node-negative breast cancer. However, the dye and radiopharmaceuticals for lymphatic mapping commonly used in Western countries are not available in Japan. Methods: To assess the optimal lymphatic mapping and the outcome after SNNS, the Japanese society for SNNS conducted a non-randomized multi-center prospective study on SNNS in early breast cancer. Primary endpoint is to evaluate the success rates and adverse events associated with various lymphatic mapping and SNNS, and secondary endpoint is to observe the outcome of patients who underwent SNNS during 5 years. After the protocol was approved by institutional review board, SNNS had been registered between July 2004 and October 2005. Results: Fourteen hundred and sixty-eight cases had pre-registration from 65 investigators at 23 institutions. As 46 cases were withdrawn for some reasons and 11 cases were diagnosed as benign disease, 1,411 cases were finally entered in this study. Dyes used for lymphatic mapping were indigocarmine, indocyanin green, patent blue, and isosulfun blue, and radiopharmaceuticals were 99m-technetium-labelled tin colloid, human serum albumin, and phytate. In 19 cases, superparamagnetic iron oxide was used for MRI- guided SNNS. As of December 2006, 98% of clinical report forms were analyzed. Dye-guided SNNS was performed in 240 cases, radio-guided SNNS in 56 cases, and combined method in 1,016 cases. Overall success rate was 99%. SNNS alone was treated in 1,138 cases (82%) and SNNS followed by axillary lymph node dissection in 258 cases (12%). Breast-conserving surgery was undergone in 1,175 cases (85%) and total mastectomy in 217 cases (15%). Dye-induced allergic adverse events were not reported. Postoperative adverse events of bleeding, wound infection and seroma were observed in about 1 % of cases, respectively. Conclusions: Dye-guided and/or radio-guided SNNS proved reliable for lymphatic mapping in breast cancer. The prognosis of all cases will be observed until 2010. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document